The Efficacy of Adalimumab as an Initial Treatment in Patients with Behçet’s Retinal Vasculitis

Background: No study has evaluated the effectiveness of Adalimumab (ADA) as first-line in treatment-naïve patients with retinal vasculitis due to Behçet’s Uveitis (BU). Objective: To compare the efficacy of ADA plus conventional therapy and conventional therapy alone as initial treatments in naïve B...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Shizhao, Huang, Zhaohao, Hu, Yunwei, Zhang, Jian, Liu, Xiuxing, Li, He, Xie, Lihui, Wen, Feng, Liang, Dan, Su, Wenru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8258106/
https://www.ncbi.nlm.nih.gov/pubmed/34239438
http://dx.doi.org/10.3389/fphar.2021.609148

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8258106/
https://www.ncbi.nlm.nih.gov/pubmed/34239438
http://dx.doi.org/10.3389/fphar.2021.609148

Ejemplares similares